Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury

Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury

Traumatic brain injury (TBI) is a major cause of death and disability, but there are currently no therapies with proven efficacy for optimizing regeneration of repair during rehabilitation. Using standard stimulation tests, as many as 40–50% of survivors of severe TBI have deficiency of one or more...

Full description

Bibliographic Details
Main Authors: Rosemary Dubiel, Librada Callender, Cynthia Dunklin, Caryn Harper, Monica Bennett, Lisa Kreber, Richard Auchus, Ramon Diaz-Arrastia
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Endocrinology
Subjects:
insulin-like growth factor I
glasgow outcome scale
disability rating scale
functional independence measure
short form 36
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00520/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2018.00520/full

Similar Items